References
- Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L, et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006; 124:315 - 329; PMID: 16439206; http://dx.doi.org/10.1016/j.cell.2005.11.044
- Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 2008; 452:492 - 496; PMID: 18337721; http://dx.doi.org/10.1038/nature06736
- McCord RA, Michishita E, Hong T, Berber E, Boxer LD, Kusumoto R, et al. SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging (Albany NY) 2009; 1:109 - 121; PMID: 20157594
- Kaidi A, Weinert BT, Choudhary C, Jackson SP. Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 2010; 329:1348 - 1353; PMID: 20829486; http://dx.doi.org/10.1126/science.1192049
- Mao Z, Hine C, Tian X, Van Meter M, Au M, Vaidya A, et al. SIRT6 promotes DNA repair under stress by activating PARP1. Science 2011; 332:1443 - 1446; PMID: 21680843; http://dx.doi.org/10.1126/science.1202723
- Kawahara TL, Michishita E, Adler AS, Damian M, Berber E, Lin M, et al. SIRT6 links histone H3 lysine 9 deacetylation to NFkappaB-dependent gene expression and organismal life span. Cell 2009; 136:62 - 74; PMID: 19135889; http://dx.doi.org/10.1016/j.cell.2008.10.052
- Zhong L, D'Urso A, Toiber D, Sebastian C, Henry RE, Vadysirisack DD, et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 2010; 140:280 - 293; PMID: 20141841; http://dx.doi.org/10.1016/j.cell.2009.12.041
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646 - 674; PMID: 21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
- Pathak S, Multani AS, Furlong CL, Sohn SH. Telomere dynamics, aneuploidy, stem cells and cancer [review]. Int J Oncol 2002; 20:637 - 641; PMID: 11836581
- Storchova Z, Pellman D. From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 2004; 5:45 - 54; PMID: 14708009; http://dx.doi.org/10.1038/nrm1276
- Rayet B, Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 1999; 18:6938 - 6947; PMID: 10602468; http://dx.doi.org/10.1038/sj.onc.1203221
- Chiao PJ, Na R, Niu J, Sclabas GM, Dong Q, Curley SA. Role of Rel/NFkappaB transcription factors in apoptosis of human hepatocellular carcinoma cells. Cancer 2002; 95:1696 - 1705; PMID: 12365017; http://dx.doi.org/10.1002/cncr.10829
- Liszt G, Ford E, Kurtev M, Guarente L. Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J Biol Chem 2005; 280:21313 - 21320; PMID: 15795229; http://dx.doi.org/10.1074/jbc.M413296200
- Mahlknecht U, Ho AD, Voelter-Mahlknecht S. Chromosomal organization and fluorescence in situ hybridization of the human Sirtuin 6 gene. Int J Oncol 2006; 28:447 - 456; PMID: 16391800
- McGlynn LCJ, Edwards J, Shiels P. Evaluating the role of sirtuins 5, 6 & 7 in breast cancer. Cancer Research 2009; 69:3
- Ma W, Stafford LJ, Li D, Luo J, Li X, Ning G, et al. GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis. J Cell Biochem 2007; 100:1376 - 1386; PMID: 17131381; http://dx.doi.org/10.1002/jcb.21140
- Zhong L, Mostoslavsky R. SIRT6: A master epigenetic gatekeeper of glucose metabolism. Transcr 2010; 1:17 - 21; PMID: 21327158; http://dx.doi.org/10.4161/trns.1.1.12143
- Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324:1029 - 1033; PMID: 19460998; http://dx.doi.org/10.1126/science.1160809
- Das C, Lucia MS, Hansen KC, Tyler JK. CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 2009; 459:113 - 117; PMID: 19270680; http://dx.doi.org/10.1038/nature07861
- Moll UM, Slade N. p63 and p73: roles in development and tumor formation. Mol Cancer Res 2004; 2:371 - 386; PMID: 15280445
- Kanfi Y, Shalman R, Peshti V, Pilosof SN, Gozlan YM, Pearson KJ, et al. Regulation of SIRT6 protein levels by nutrient availability. FEBS Lett 2008; 582:543 - 548; PMID: 18242175; http://dx.doi.org/10.1016/j.febslet.2008.01.019
- Longo VD, Fontana L. Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol Sci 2010; 31:89 - 98; PMID: 20097433; http://dx.doi.org/10.1016/j.tips.2009.11.004
- Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003; 425:191 - 196; PMID: 12939617; http://dx.doi.org/10.1038/nature01960
- Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249:912 - 915; PMID: 2144057; http://dx.doi.org/10.1126/science.2144057
- Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 2000; 407:645 - 648; PMID: 11034215; http://dx.doi.org/10.1038/35036614
- Hine CM, Seluanov A, Gorbunova V. Use of the Rad51 promoter for targeted anti-cancer therapy. Proc Natl Acad Sci USA 2008; 105:20810 - 20815; PMID: 19106292; http://dx.doi.org/10.1073/pnas.0807990106